Prostaglandin synthetase inhibition in group B streptococcal shock: hematologic and hemodynamic effects.
A rabbit model of group B Streptococcal (GBS) shock was used to study the effects of prostaglandin synthetase inhibition on the hemodynamic and hematologic response to GBS shock. The infusion of heat-killed GBS in groups I and II produced significant decreases in mean arterial pressure, neutrophil counts, and platelet counts (p less than 0.05), and significant rises in concentrations of thromboxane B2 and 6-Keto-PGF1 alpha, the stable metabolites of thromboxane A2 and prostacyclin (p less than 0.05). Administration of indomethacin (4 mg/kg) after GBS infusion (group II) was associated with a significant rise in mean arterial pressure and a significant decline in thromboxane B2 and 6-Keto-PGF1 alpha concentrations (p less than 0.05) but had no effect on GBS-induced hematologic alterations. Indomethacin administration before GBS infusion (group III) prevented alterations in mean arterial pressure and was associated with a decrease in thromboxane B2 and 6-Keto-PGF1 alpha concentrations. Indomethacin in group III did not prevent neutropenia and thrombocytopenia and may have exacerbated neutropenia. Alteration of experimental GBS shock with prostaglandin synthetase inhibition produces disparate hemodynamic and hematologic response.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D001639:Bicarbonates / Q000097:blood; D001784:Blood Gas Analysis; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D016861:Cyclooxygenase Inhibitors; D004195:Disease Models, Animal; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D007223:Infant; D007958:Leukocyte Count / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology; D010976:Platelet Count / Q000187:drug effects; D011817:Rabbits; D012772:Shock, Septic / Q000097:blood / Q000382:microbiology / Q000503:physiopathology*; D013290:Streptococcal Infections / Q000097:blood / Q000382:microbiology / Q000503:physiopathology*; D013292:Streptococcus agalactiae / Q000302:isolation & purification; D013929:Thromboxane B2 / Q000097:blood
D001639:Bicarbonates; D016861:Cyclooxygenase Inhibitors; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D007213:Indomethacin